Published in CA Cancer J Clin on January 04, 2012
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol (2013) 2.80
Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement. J Clin Endocrinol Metab (2012) 2.78
Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov (2012) 2.39
Utilization of renal mass biopsy in patients with renal cell carcinoma. Urology (2014) 2.23
Papillary thyroid microcarcinoma: an over-treated malignancy? World J Surg (2014) 2.15
Trends in esophageal adenocarcinoma incidence and mortality. Cancer (2012) 2.03
Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. Proc Natl Acad Sci U S A (2013) 1.76
Causes of death in long-term survivors of head and neck cancer. Cancer (2014) 1.68
Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol (2012) 1.64
Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol (2013) 1.63
Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer. J Natl Cancer Inst (2013) 1.60
Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut (2013) 1.48
Ocular melanoma: an overview of the current status. Int J Clin Exp Pathol (2013) 1.43
Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer. PLoS One (2015) 1.43
Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells. PLoS One (2016) 1.39
Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett (2012) 1.36
Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis. Am J Hum Genet (2016) 1.15
Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Mol Cancer (2014) 1.05
Cancer prevention for the next generation. J Adolesc Health (2013) 1.04
Psychosocial correlates of sun protection behaviors among U.S. Hispanic adults. J Behav Med (2014) 1.01
Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database. Pharmacoepidemiol Drug Saf (2012) 1.00
Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008. J Am Coll Surg (2012) 0.97
Therapeutic options for the management of pancreatic cancer. World J Gastroenterol (2014) 0.96
Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer (2014) 0.96
Melanoma risk loci as determinants of melanoma recurrence and survival. J Transl Med (2013) 0.94
Pancreatic cancer and its stroma: a conspiracy theory. World J Gastroenterol (2014) 0.94
A latent class analysis of cancer risk behaviors among U.S. college students. Prev Med (2014) 0.92
Herpes and polyoma family viruses in thyroid cancer. Oncol Lett (2016) 0.92
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Sci Transl Med (2015) 0.91
Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma. Pigment Cell Melanoma Res (2013) 0.91
Diagnostic value of multiple tumor markers for patients with esophageal carcinoma. PLoS One (2015) 0.91
Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol (2013) 0.90
Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA). Br J Cancer (2015) 0.89
Surgery is an essential component of multimodality therapy for patients with locally advanced esophageal adenocarcinoma. J Gastrointest Surg (2013) 0.88
A Novel Multivariate Index for Pancreatic Cancer Detection Based On the Plasma Free Amino Acid Profile. PLoS One (2015) 0.88
Increasing incidence of melanoma among middle-aged adults: an epidemiologic study in Olmsted County, Minnesota. Mayo Clin Proc (2014) 0.88
Minimally invasive local therapies for liver cancer. Cancer Biol Med (2014) 0.88
Highlights from a workshop on opportunities for cancer prevention during preadolescence and adolescence. J Adolesc Health (2013) 0.88
Diet and lifestyle factors and risk of subtypes of esophageal and gastric cancers: classification tree analysis. Ann Epidemiol (2013) 0.87
Rising incidence of mucosal melanoma of the head and neck in the United States. J Skin Cancer (2012) 0.87
Hepatitis B and C in African Americans: current status and continued challenges. Clin Gastroenterol Hepatol (2013) 0.87
Trends in Prevalence of Thyroid Cancer Over Three Decades: A Retrospective Cohort Study of 17,526 Surgical Patients. World J Surg (2016) 0.86
Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030. J Clin Oncol (2016) 0.85
Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma. Oncotarget (2015) 0.85
A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma. Best Pract Res Clin Gastroenterol (2014) 0.85
Nutrients related to one-carbon metabolism and risk of renal cell cancer. Cancer Causes Control (2012) 0.85
Activation of c-Myc and Cyclin D1 by JCV T-Antigen and β-catenin in colon cancer. PLoS One (2014) 0.85
Descriptive epidemiology of human thyroid cancer: experience from a regional registry and the "volcanic factor". Front Endocrinol (Lausanne) (2013) 0.85
Association of Visceral Fat Area, Smoking, and Alcohol Consumption with Reflux Esophagitis and Barrett's Esophagus in Japan. PLoS One (2015) 0.84
Neoadjuvant chemoradiotherapy for esophageal/gastroesophageal carcinoma. J Gastrointest Oncol (2013) 0.83
A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma. Sci Rep (2015) 0.83
Screening for distress in routine oncological care-a survey in 520 melanoma patients. PLoS One (2013) 0.83
Minimally invasive esophagectomy for dysplastic Barrett's esophagus. World J Surg (2015) 0.83
Conditional survival in patients with thyroid cancer. Thyroid (2014) 0.82
Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide. Hum Gene Ther Clin Dev (2014) 0.82
Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma. BMC Cancer (2013) 0.82
Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities. J Thorac Dis (2014) 0.82
Presenting symptoms predict local staging of anal cancer: a retrospective analysis of 86 patients. BMC Gastroenterol (2016) 0.81
Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology. Sci Rep (2016) 0.81
Improving the efficacy of appearance-based sun exposure interventions with the terror management health model. Psychol Health (2014) 0.81
Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. J Gastroenterol Hepatol (2016) 0.80
Genome-wide promoter methylome of small renal masses. PLoS One (2013) 0.80
Role of liver stem cells in hepatocarcinogenesis. World J Stem Cells (2014) 0.79
A pancreatic tumor-specific biomarker characterized in humans and mice as an immunogenic onco-glycoprotein is efficient in dendritic cell vaccination. Oncotarget (2015) 0.79
Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model. Endocr Relat Cancer (2015) 0.79
Griffipavixanthone, a dimeric xanthone extracted from edible plants, inhibits tumor metastasis and proliferation via downregulation of the RAF pathway in esophageal cancer. Oncotarget (2016) 0.79
A pilot study of genetic variants in dopamine regulators with indoor tanning and melanoma. Exp Dermatol (2013) 0.79
Impact of coverage-dependent marginal costs on optimal HPV vaccination strategies. Epidemics (2015) 0.79
Powerful inhibition of experimental human pancreatic cancers by receptor targeted cytotoxic LH-RH analog AEZS-108. Oncotarget (2013) 0.79
Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells. Drug Des Devel Ther (2015) 0.79
Escalation of oncologic services at the end of life among patients with gynecologic cancer at an urban, public hospital. J Oncol Pract (2015) 0.79
Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma. Oncotarget (2016) 0.79
Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma. BMC Cancer (2014) 0.78
Hepatitis B among Asian Americans: Prevalence, progress, and prospects for control. World J Gastroenterol (2015) 0.78
Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma. Surgery (2012) 0.78
TRAF6 regulates melanoma invasion and metastasis through ubiquitination of Basigin. Oncotarget (2016) 0.78
Radiological assessment of anal cancer: an overview and update. Infect Agent Cancer (2016) 0.78
Gender differences in benign renal masses. World J Urol (2013) 0.78
Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project. Cancer Epidemiol Biomarkers Prev (2015) 0.78
Endoscopic mucosal resection versus esophagectomy for intramucosal adenocarcinoma in the setting of barrett's esophagus. Surg Endosc (2017) 0.78
Perioperative and Palliative Chemotherapy for Esophageal Cancer. Viszeralmedizin (2015) 0.78
Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways. Oncotarget (2015) 0.77
Ten years of progress in head and neck cancers. J Natl Compr Canc Netw (2012) 0.77
NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project. Cancer Prev Res (Phila) (2015) 0.77
Dietary Risk Reduction Factors for the Barrett's Esophagus-Esophageal Adenocarcinoma Continuum: A Review of the Recent Literature. Curr Nutr Rep (2015) 0.77
Comparative Study of 17-AAG and NVP-AUY922 in Pancreatic and Colorectal Cancer Cells: Are There Common Determinants of Sensitivity? Transl Oncol (2014) 0.77
Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus. Dig Dis Sci (2014) 0.77
A potential role for immunotherapy in thyroid cancer by enhancing NY-ESO-1 cancer antigen expression. Thyroid (2014) 0.77
Dietary flavonoid intake and Barrett's esophagus in western Washington State. Ann Epidemiol (2015) 0.76
Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data. Med Care (2016) 0.76
An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males. Dis Esophagus (2016) 0.76
Activity-based cost analysis of hepatic tumor ablation using CT-guided high-dose rate brachytherapy or CT-guided radiofrequency ablation in hepatocellular carcinoma. Radiat Oncol (2016) 0.76
Temporal trends of esophageal disorders by age in the Cerner Health Facts database. Ann Epidemiol (2015) 0.76
Dietary Flavonols Intake and Risk of Esophageal and Gastric Cancer: A Meta-Analysis of Epidemiological Studies. Nutrients (2016) 0.76
Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma. Mod Pathol (2015) 0.76
Obesity, diabetes, serum glucose, and risk of primary liver cancer by birth cohort, race/ethnicity, and sex: Multiphasic health checkup study. Cancer Epidemiol (2016) 0.76
Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis. Int J Cancer (2014) 0.76
Trends of Thyroid Cancer in Israel: 1980-2012. Rambam Maimonides Med J (2016) 0.76
Is open surgery for head and neck cancers truly declining? Eur Arch Otorhinolaryngol (2013) 0.76
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin (2012) 14.47
Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86
Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev (2010) 12.60
Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin (2004) 12.55
Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin (2014) 11.09
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
International variation in prostate cancer incidence and mortality rates. Eur Urol (2012) 8.04
Breast cancer statistics, 2013. CA Cancer J Clin (2013) 7.35
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer (2007) 6.84
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
Breast cancer statistics, 2011. CA Cancer J Clin (2011) 6.12
Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer (2002) 6.08
Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin (2007) 5.67
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin (2007) 5.31
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Cancer mortality in the United States by education level and race. J Natl Cancer Inst (2007) 4.77
Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin (2006) 4.73
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer (2006) 4.71
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2009) 4.49
Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol (2008) 4.49
Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer (2013) 4.24
The global burden of cancer: priorities for prevention. Carcinogenesis (2009) 3.73
Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin (2014) 3.59
Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin (2012) 3.58
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev (2009) 3.08
Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med (2005) 3.02
Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst (2006) 2.66
The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer (2010) 2.63
Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol (2011) 2.58
Cancer statistics for African Americans. CA Cancer J Clin (2002) 2.45
Cancer statistics for African Americans, 2013. CA Cancer J Clin (2013) 2.44
Insurance status and stage of cancer at diagnosis among women with breast cancer. Cancer (2007) 2.43
International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2011) 2.40
Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev (2012) 2.39
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (2002) 2.38
Trends in breast cancer by race and ethnicity. CA Cancer J Clin (2004) 2.19
Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Biomarkers Prev (2011) 2.06
Tobacco control in the United States--recent progress and opportunities. CA Cancer J Clin (2009) 1.97
The influence of sex, race/ethnicity, and educational attainment on human immunodeficiency virus death rates among adults, 1993-2007. Arch Intern Med (2012) 1.92
Cancer statistics for Hispanics, 2003. CA Cancer J Clin (2003) 1.88
Recent trends in Black-White disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev (2008) 1.86
Pancreatic cancer death rates by race among US men and women, 1970-2009. J Natl Cancer Inst (2013) 1.85
Incidence of noncutaneous melanomas in the U.S. Cancer (2005) 1.85
Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007. J Urol (2010) 1.83
How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking? Tob Control (2006) 1.80
Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. J Clin Oncol (2010) 1.58
Prevalence of prehypertension and its relationship to risk factors for cardiovascular disease in Jamaica: analysis from a cross-sectional survey. BMC Cardiovasc Disord (2008) 1.55
State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol Biomarkers Prev (2011) 1.54
Pesticide contamination inside farm and nonfarm homes. J Occup Environ Hyg (2005) 1.52
Insurance status, comorbidity level, and survival among colorectal cancer patients age 18 to 64 years in the National Cancer Data Base from 2003 to 2005. J Clin Oncol (2009) 1.49
Trends in the incidence of colorectal cancer in relation to county-level poverty among blacks and whites. J Natl Med Assoc (2008) 1.42
A new method of predicting US and state-level cancer mortality counts for the current calendar year. CA Cancer J Clin (2004) 1.42
Management trends in stage I testicular seminoma: Impact of race, insurance status, and treatment facility. Cancer (2014) 1.41
Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev (2012) 1.36
Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst (2008) 1.34
A new method of estimating United States and state-level cancer incidence counts for the current calendar year. CA Cancer J Clin (2007) 1.33
Trends in colorectal cancer incidence rates by age, race/ethnicity, and indices of access to medical care, 1995–2004 (United States). Cancer Causes Control (2009) 1.33
The impact of health insurance status on stage at diagnosis of oropharyngeal cancer. Cancer (2007) 1.30
Cancer incidence patterns among adolescents and young adults in the United States. Cancer Causes Control (2005) 1.25
Mortality and exposure response among 14,458 electrical capacitor manufacturing workers exposed to polychlorinated biphenyls (PCBs). Environ Health Perspect (2006) 1.25
Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis? Arch Otolaryngol Head Neck Surg (2007) 1.22
Widening socioeconomic disparities in cervical cancer mortality among women in 26 states, 1993-2007. Cancer (2012) 1.21
Changes in smoking prevalence among U.S. adults by state and region: Estimates from the Tobacco Use Supplement to the Current Population Survey, 1992-2007. BMC Public Health (2011) 1.21
Association of cutaneous melanoma incidence with area-based socioeconomic indicators-United States, 2004-2006. J Am Acad Dermatol (2011) 1.20
Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol (2011) 1.20
Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999. Cancer Epidemiol Biomarkers Prev (2004) 1.19
Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry (2005) 1.18
Body mass index in young adulthood and premature death: analyses of the US National Health Interview Survey linked mortality files. Am J Epidemiol (2011) 1.15